Archives

Category Archive for: ‘drug product injuries’

Pennsylvania Treasurer Joe Torsella calls out big pharma amidst growing opioid crisis in PA

In an opinion piece for Philly.com, Pennsylvania Treasurer, Joe Torsella, calls on the pharmaceutical industry to be held accountable for its role in the opioid crisis currently sweeping Pennsylvania. Big pharma profits while people die In his piece, Torsella explained that thirteen people die every day in cities across the commonwealth as a result of an opioid related drug overdose. …

Read More

Healthcare bill rushed through committee without public hearing aims to slash rights of citizens to fair compensation in court

The United States House of Representatives may vote this week on a bill (House Resolution 1215) that will do grave harm to the rights of citizens to seek justice in court for damages caused by medical malpractice, defective drugs, or defective medical devices. The bill is called the Protecting Access to Care Act and it was rushed through committee without …

Read More

Johnson & Johnson loses in talcum powder trial to the tune of $110M

Last Monday Messa & Associates wrote about the third Philadelphia jury to find Johnson & Johnson liable for damages regarding defective mesh implants. Last Thursday, a St. Louis jury handed up a $110 million verdict to a woman from Virginia who claims that her ovarian cancer was caused by the company’s talcum products. Lois Slemp, 62, said she used Johnson …

Read More

White Coat Marketing: More unscrupulous behavior from the pharmaceutical industry

Novo Nordisk, a Danish pharmaceutical company focused on manufacturing medicinal treatments for diabetes, obesity, Haemophilia, growth hormone therapy, and hormone replacement therapy, has been accused in a lawsuit filed on behalf of the Federal Government of engaging in a “white coat marketing scheme” to persuade doctors to prescribe three of its diabetes treatments – NovoLog, Levimir, and Victoza. What is …

Read More

FDA warns Pfizer Inc. of “significant violations” at a manufacturing plant

Hospira

Last month, the United States Food and Drug Administration sent a letter to pharmaceutiucal company, Pfizer, Inc., warning of “significant violations” at a Hospira manufacturing plant. Pfizer acquired Hospira in a $17 billion deal in 2015. An inspection was conducted from May to June of 2015 at a McPherson, Kansas Hospira drug plant, and the inspection cited “significant violations of …

Read More

Page 1 of 1312345»10...Last »

Philadelphia | Downingtown | Conshohocken | Cherry Hill | Collingswood | Linwood | Roselle